Denegetu Amenu Wesen, Birru Tadesse Gossaye, Asemahaegn Eshetu Wassie
World Health Organization, Expanded Programme on Immunization, Maternal Child Health and Nutrition, Addis Ababa, Ethiopia.
World Health Organization, Expanded Programme on Immunization, Maternal Child Health and Nutrition, Islamabad, Pakistan.
Pan Afr Med J. 2024 Sep 27;49:23. doi: 10.11604/pamj.2024.49.23.37746. eCollection 2024.
following the detection of vaccine-derived poliovirus in 2019 in Ethiopia, response activities have been conducted including strengthening disease surveillance activities.
trend analysis study design of acute flaccid paralysis and measles surveillance data for the years 2021 and 2022 for Southwest Ethiopia Region was used. The non-polio acute flaccid paralysis (AFP) rate and stool adequacy rates were used to assess the AFP surveillance. Whereas the non-measles febrile rash rate was used to assess the measles surveillance.
a total of 68 AFP cases in 2022 and 49 in 2021 have been reported as of week 41 and investigated for polio analysis. All cases were discarded in 2022 and 1 cVDPV was detected in 2021. The stool adequacy rate for 2022 was 96%; whereas, 94% in 2021. The annualized non-polio AFP rate was 4.8/100,000 for 2022 and 3.8/100,000 for 2021, which the former is much higher though both met the minimum expected rate in outbreak areas of 3/100,000. A total of 155 suspected measles cases in 2022 and 38 in 2021 have been investigated for IGM analysis. In 2022, 9 and 1 in 2021 Igm positive for measles were identified. The non-measles febrile rash rate for 2022 was 4.6/100,000; whereas, 1.2/100,000 for 2021.
there is an improvement in the sensitivity of AFP and measles surveillance for Southwest Ethiopia Region in 2022. Sustaining high-quality measles and AFP surveillance is suggested to maintain measles and polio-free statuses.
2019年在埃塞俄比亚检测到疫苗衍生脊髓灰质炎病毒后,已开展应对活动,包括加强疾病监测活动。
采用趋势分析研究设计,对埃塞俄比亚西南部地区2021年和2022年急性弛缓性麻痹和麻疹监测数据进行分析。非脊髓灰质炎急性弛缓性麻痹(AFP)发病率和粪便合格率用于评估AFP监测情况。而非麻疹发热皮疹发病率用于评估麻疹监测情况。
截至第41周,2022年共报告68例AFP病例,2021年报告49例,并对其进行脊髓灰质炎分析调查。2022年所有病例均被排除,2021年检测到1例循环疫苗衍生脊髓灰质炎病毒(cVDPV)。2022年粪便合格率为96%;2021年为94%。2022年非脊髓灰质炎AFP年化发病率为4.8/10万,2021年为3.8/10万,尽管两者均达到疫情地区最低预期发病率3/10万,但前者要高得多。2022年共调查155例疑似麻疹病例,2021年调查38例进行IgM分析。2022年,9例麻疹IgM呈阳性,2021年为1例。2022年非麻疹发热皮疹发病率为4.6/1万;2021年为1.2/1万。
2022年埃塞俄比亚西南部地区AFP和麻疹监测的敏感性有所提高。建议持续开展高质量的麻疹和AFP监测,以维持无麻疹和无脊髓灰质炎状态。